India to Iraq: Moxifloxacin Export Trade Route

The India to Iraq Moxifloxacin corridor is one of India's established pharmaceutical export routes, with 44 shipments documented worth a combined $702.2K USD. The route is dominated by AJANTA PHARMA LIMITED, which alone accounts for roughly 63% of all export value, reflecting the consolidated nature of India's moxifloxacin manufacturing sector.

Across 14 active suppliers, the average shipment value stands at $16.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 78% of all shipments, consistent with moxifloxacin's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 32 days port-to-port. The route has recorded an annual growth rate of 24.3%, placing it at rank #12 among India's top moxifloxacin export destinations globally.

On the import side, key buyers of Indian moxifloxacin in Iraq include HAWKARY PHARMACEUITCAL CO.*, HAWKARY PHARMACEUITCAL CO.* , KAWKAB SCIENTIFIC BUREAU and 14 others. HAWKARY PHARMACEUITCAL CO.* is the single largest importer with 11 shipments valued at $212.7K USD.

India's moxifloxacin exports to Iraq are driven primarily by a handful of large-scale manufacturers. AJANTA PHARMA LIMITED with 22 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 14 active exporters signals a competitive but concentrated market — buyers in Iraq benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — AJANTA PHARMA LIMITED, AJANTA PHARMA LIMITED , INNOVA CAPTAB LIMITED — together account for 85% of total trade value on this route. The average shipment value of $16.0K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as shipment under consignment sale:apdropseye drops[moxifloxacin hydrochloride eyedrops 0.5w/v][55050x1=55050 bottles] and apdrops eye drops[moxifloxacin hydrochloride eye drops 0.5w/v][37350 x 1 = 37350bottles]cont:as per invoicenos, suggesting that buyers in Iraq tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, HAWKARY PHARMACEUITCAL CO.* is the largest importer with 11 shipments worth $212.7K USD — representing 30% of all moxifloxacin imports from India on this route. A total of 17 buyers are active on this corridor.